期刊文献+

维他昔布表观油水分配系数和平衡溶解度的测定 被引量:4

Determination of Apparent Oil-water Partition Coefficient and Equilibrium Solubility of Vitacoxib
原文传递
导出
摘要 目的:研究维他昔布在不同介质溶液中的表观油水分配系数和平衡溶解度。方法:采用高效液相色谱法和饱和溶解度法测定维他西布37℃时在0.1mol/L盐酸,pH2.0、5.8、6.8、7.4的磷酸盐缓冲液(PBS液),水,0.5%十二烷基硫酸钠和0.5%聚山梨酯80的溶液中的平衡溶解度;通过维他昔布分配平衡后在油相(正辛醇)和水相的浓度比,计算表观油水分配系数的lg值(lgP)。结果:维他昔布在上述溶液中的平衡溶解度分别为6.62、8.66、6.65、14.41、27.38、55.65、96.17、18.37μg/ml,lgP分别为0.45、0.61、0.43、0.40、0.44、0.47、0.35、0.21。结论:维他昔布是亲脂性药物,在水中溶解度小,在0.5%十二烷基硫酸钠溶液中的溶解度最大,推测其在体内吸收较差。 OBJECTIVE: To study the equilibrium solubility and the apparent oil-water partition coefficient of vitacoxib in different medium. METHODS: The equilibrium solubility of vitacoxib in 0.1 mol/L hydrochloric acid, PBS solution (pH 2.0, 5.8, 6.8, 7.4), water, 0.5% sodium dodecyl sulfate solution and 0.5% Polysorbate 80 solution at 37 ℃ were determined by HPLC and saturation method. The apparent oil-water partition coefficient was calculated with concentration ratio of vitacoxib in oil phase (n-octanol) and water phase after partition equilibrium. RESULTS: The equilibrium solubility of vitacoxib were 6.62, 8.66, 6.65, 14.41, 27.38, 55.65, 96.17 and 18.37 μg/ml; and the lgP of apparent oil-water partition coefficient of vitacoxib were 0.45, 0.61, 0.43, 0.40, 0.44, 0.47, 0.35 and 0.21, respectively. CONCLUSIONS: Vitacoxib is a lipophilic drug, and the solubility of vitacoxib in water is poor. The solubility of vitacoxib in 0.5% sodium dodecyl sulfate solution is the largest, which indicates that in vivo absorption of vitacoxib is not good.
出处 《中国药房》 CAS CSCD 2013年第25期2332-2334,共3页 China Pharmacy
关键词 维他昔布 表观油水分配系数 平衡溶解度 高效液相色谱法 Vitacoxib Apparent oil-water partition coeficient Equilibrium solubility HPLC
  • 相关文献

参考文献3

二级参考文献17

共引文献41

同被引文献42

  • 1罗明生,高天惠.药剂辅料大全[M].成都:四川科技出版社,1992:605-607.
  • 2Vane JR,Bakhle YS,Botting RM.Cyclooxygenases 1 and 2[J].Annu Rev Pharmacol Toxicol,1998,38:97.
  • 3Chandrasekharan NV,Dai H,Roos KL,et al.COX-3,a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs:cloning,structure,and expression[J].Proc Natl Acad Sci USA,2002,99(21):13926.
  • 4Ferraz JG,Sharkey KA,Reuter BK,et al.Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia:Role in resistance to damage[J].Gastroenterol,1997,113(1):l95.
  • 5Crofford LJ,Tan B,McCarthy CJ,et al.Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes[J].Arthritis Rheum,1997,40(2):226.
  • 6Raspollini MR,Amunni G,Villanucci A,et al.COX-2 status in relation to tumor microvessel density and VEGF expression:Analysis in ovarian carcinoma patients with low versus high survival rates[J].Oncol Rep,2004,11(2):309.
  • 7Crofford LJ.COX-1 and COX-2 tissue expression:Implications and predictions[J].J Rheumatol Suppl,1997,49:15.
  • 8Nanji AA,Jokelainen K,Fotouhinia M,et al.Increased severity of alcoholic liver injury in female rats:Role of oxidative stress,endotoxin,and chemokines[J].Am J Physiol Gastrointest Liver Physiol,2001,281(6):G1348.
  • 9Moore RA,Deny S,McQuay HJ,et al.Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs:Balancing gastrointestinal and cardiovascular risk[J].BMC Musculoskelet Disord,2007,8:73.
  • 10Brooks PM,Day RO.COX-2 inhibitors[J].Med J Aust,2000,173(8):433.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部